Market By Type, Technology, Age Group, Delivery Mode And Geography | Forecast 2019-2028
Triton Market Research’s report on the Latin American influenza vaccines market illustrates that the industry is anticipated to proliferate at a CAGR of 6.49% in terms of revenue, during the forecasted period 2019-2028.
Report scope can be customized per your requirements. Request For Customization
The countries reviewed in the Latin American influenza vaccines market are:
• Mexico
• Brazil
• Rest of Latin America
In Brazil, there is a need for an annual immunization in mass campaigns for reaching high coverage rates. Such national campaigns have gained a coverage rate of between 71.8% and 87.3% in the country. The provision of the influenza vaccine in the country is fostered due to the recommendation of infant vaccination by the Brazilian National Immunization Program (PNI). One of the challenges of these vaccines is that they cannot be stockpiled due to its annual changes in their composition. Being registered in the Family Health Program, aging individuals and non-smokers, suffering from several chronic diseases, were associated with influenza vaccine uptake positively. Thus, Brazil’s influenza vaccines market shows a positive trend.
In Mexico, the number of cases reported during the influenza season of 2018-2019, reached about 75,000 cases. The majority of the influenza vaccines in the country are trivalent, which contains two influenza A strains and a single B strain. Local governments in the countries in Latin America, along with the Pan American Health Organization (PAHO’s) Technical Advisory Group on Vaccine-preventable Diseases (TAG), play a significant role in enhancing the vaccination coverage rate in the region. These factors are likely to boost the demand for the country’s influenza vaccines market in the coming years.
Merck is a company involved in the manufacturing and distribution of pharmaceuticals. The company has four business operations, namely Pharmaceutical, Healthcare Services, Animal Health and Alliances. Merck provides preventive agents to treat influenza, cardiovascular diseases, Type 2 diabetes, nasal allergy symptoms, asthma, chronic hepatitis C virus, HIV-1 infection, intra-abdominal infections and fertility diseases.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN AMERICA INFLUENZA VACCINES MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. QUADRIVALENT IS THE DOMINANT TYPE OF INFLUENZA VACCINE
2.2.2. INJECTION IS FASTEST-GROWING DELIVERY MODE
2.2.3. CELL-BASED TECHNOLOGY IS RAPIDLY GROWING TECHNOLOGY IN THE MARKET
2.2.4. ADULT AGE GROUP IS MAJORLY CONTRIBUTING IN THE MARKET
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. INTENSITY OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. ADVANCEMENT IN TECHNOLOGY
2.6.2. INITIATIVES TAKEN UP BY THE GOVERNMENT
2.7. MARKET RESTRAINTS
2.7.1. HIGH COST OF DEVELOPMENT
2.8. MARKET OPPORTUNITIES
2.8.1. GROWTH IN THE CASES OF INFLUENZA
2.9. MARKET CHALLENGES
2.9.1. COMPLEX DEVELOPMENT PROCESS
3. INFLUENZA VACCINES MARKET OUTLOOK - BY TYPE
3.1. QUADRIVALENT VACCINE
3.2. TRIVALENT VACCINE
4. INFLUENZA VACCINES MARKET OUTLOOK - BY TECHNOLOGY
4.1. EGG-BASED TECHNOLOGY
4.2. CELL-BASED TECHNOLOGY
5. INFLUENZA VACCINES MARKET OUTLOOK - BY AGE GROUP
5.1. PEDIATRIC AGE GROUP
5.2. ADULT AGE GROUP
6. INFLUENZA VACCINES MARKET OUTLOOK - BY DELIVERY MODE
6.1. INJECTION
6.2. NASAL SPRAY
7. INFLUENZA VACCINES MARKET – LATIN AMERICA
7.1. BRAZIL
7.2. MEXICO
7.3. REST OF LATIN AMERICA
8. COMPETITIVE LANDSCAPE
8.1. MERCK SHARP & DOHME CORP
8.2. NOVARTIS AG
8.3. PFIZER INC
8.4. SANOFI
8.5. BIODIEM
8.6. EMERGENT BIOSOLUTIONS INC
8.7. F. HOFFMANN-LA ROCHE LTD
8.8. GLAXOSMITHKLINE PLC
8.9. ABBOTT
8.10. CSL LIMITED
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA INFLUENZA VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LATIN AMERICA INFLUENZA VACCINES MARKET, BY TYPE, 2019-2028 (IN $ MILLION)
TABLE 4: LATIN AMERICA INFLUENZA VACCINES MARKET, BY TECHNOLOGY, 2019-2028 (IN $ MILLION)
TABLE 5: LATIN AMERICA INFLUENZA VACCINES MARKET, BY AGE GROUP, 2019-2028 (IN $ MILLION)
TABLE 6: LATIN AMERICA INFLUENZA VACCINES MARKET, BY DELIVERY MODE, 2019-2028 (IN $ MILLION)
TABLE 7: LATIN AMERICA INFLUENZA VACCINES MARKET, BY COUNTRY, 2019-2028 (IN $ MILLION)
FIGURE 1: LATIN AMERICA INFLUENZA VACCINES MARKET, BY SOURCE, 2019 & 2028 (IN %)
FIGURE 2: LATIN AMERICA QUADRIVALENT INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)
FIGURE 3: LATIN AMERICA INJECTION DELIVERY MODEL MARKET, 2019-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA CELL BASED TECHNOLOGY MARKET, 2019-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA ADULT AGE GROUP MARKET, 2019-2028 (IN $ MILLION)
FIGURE 6: PORTER’S FIVE FORCE ANALYSIS
FIGURE 7: MARKET ATTRACTIVENESS INDEX
FIGURE 8: LATIN AMERICA INFLUENZA VACCINES MARKET, BY QUADRIVALENT VACCINE, 2019-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA INFLUENZA VACCINES MARKET, BY TRIVALENT VACCINES, 2019-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA INFLUENZA VACCINES MARKET, BY EGG-BASED TECHNOLOGY, 2019-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA INFLUENZA VACCINES MARKET, BY CELL-BASED TECHNOLOGY, 2019-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA INFLUENZA VACCINES MARKET, BY PEDIATRIC AGE GROUP, 2019-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA INFLUENZA VACCINES MARKET, BY ADULT AGE GROUP, 2019-2028 (IN $ MILLION)
FIGURE 14: LATIN AMERICA INFLUENZA VACCINES MARKET, BY INJECTION, 2019-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA INFLUENZA VACCINES MARKET, BY NASAL SPRAY, 2019-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA INFLUENZA VACCINES MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
FIGURE 17: BRAZIL INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)
FIGURE 18: MEXICO INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)
FIGURE 19: REST OF LATIN AMERICA INFLUENZA VACCINES MARKET, 2019-2028 (IN $ MILLION)